Psychiatry & Psychotherapy Podcast
Obesity and Weight Loss with Endocrinologist Rocio Salas-Whalen
Sep 23, 2022
Dr. Rocio Salas-Whalen, owner of New York Endocrinology and a renowned expert in diabetes and obesity, dives into the evolving understanding of obesity as a chronic disease. She discusses its complex ties to type 2 diabetes and the rising awareness post-COVID-19. The conversation highlights groundbreaking GLP-1 and GIP medications that reshape the weight loss landscape, discussing their benefits and psychological impacts on food cravings. Dr. Salas-Whalen also addresses the challenges posed by insurance companies in treating obesity, pushing for a more proactive medical approach.
41:15
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Obesity is increasingly recognized as a complex, chronic disease, necessitating a multifaceted approach to its treatment beyond traditional lifestyle changes.
- Recent advancements in obesity medications, particularly GLP-1 receptor agonists, have shown significant promise in facilitating weight loss and improving metabolic health.
Deep dives
Understanding Obesity as a Chronic Disease
Obesity is increasingly recognized as a chronic, multifactorial disease rather than merely a lifestyle issue. This change in understanding began with the World Health Organization's classification in 1942 and was reinforced by the American Medical Association in 2013. The podcast highlights how this new perspective allows healthcare providers to better address the underlying causes of obesity, linking it closely with conditions such as type 2 diabetes and metabolic disorders. Professionals are now encouraged to discuss obesity in-depth, focusing on the complexities rather than oversimplified solutions like 'eat less, exercise more.'
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
